triparanol has been researched along with cyclizine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Hopkins, E; Hruban, Z; Slesers, A | 1 |
Martin, DL; Wright, HB | 1 |
4 other study(ies) available for triparanol and cyclizine
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Drug-induced and naturally occurring myeloid bodies.
Topics: Amino Alcohols; Aminoglutethimide; Animals; Anticholesteremic Agents; Benzyl Compounds; Biphenyl Compounds; Chloroquine; Clofibrate; Cyclizine; Diphenhydramine; Endoplasmic Reticulum; Ethers; Haloperidol; Histamine H1 Antagonists; Hydroxyzine; Imidazoles; Inclusion Bodies; Kidney; Liver; Lysosomes; Male; Meclizine; Mice; Microscopy, Electron; Piperazines; Pyrrolidines; Rats; Triparanol; Trophoblasts | 1972 |
Hypocholesteremic agents. IV. Some substituted piperazines.
Topics: Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry, Physical; Cholesterol; Crystallization; Cyclizine; Depression, Chemical; Elements; Liver; Organ Size; Piperazines; Triparanol | 1968 |